CAR-T Cell Therapy Market Size to Surpass USD 14.42 Billion by 2030
Global CAR-T Cell Therapy Market Size was valued at USD 2.72 billion in 2022 and is projected to grow from USD 14.42 billion by 2030 exhibiting a CAGR of 18.5% during forecast period. The growing prevalence of cancer in the population and rising healthcare burden due to these diseases are the key factors driving the market growth.
A rise in clinical trials and R&D programs by leading companies to offer advanced therapies and more efficient drugs for CAR-T cell therapy are the major elements supporting market expansion.
Surging blood cancer awareness among the population is surging CAR-T cell therapy demand. An increase in healthcare spending and the rising incidence of non-Hodgkin's lymphoma in both developed and developing countries are boosting market growth.
However, lack of awareness regarding different cancer conditions in certain countries and decrease in eligible patients for CAR-T cell therapy are hampering market growth.
North America holds a substantial global CAR-T cell therapy market share. Market expansion in the region is driven by rapid innovations in CAR-T cell therapies and novel product introductions by key companies.
The Asia Pacific market is set to rise at the highest CAGR over the projected period. An increase in clinical trials, growing acceptance of recent treatments among individuals, and rising focus on product approvals by prominent market players are boosting market development in the region.
ارسال به دوستان